Shingles Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
Condition: ShinglesInterventions: Biological: zoster vaccine live (Oka/Merck); Biological: Comparator: placebo (unspecified)Sponsor: Merck Sharp & Dohme Corp.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2005 Category: Research Source Type: clinical trials

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
Conditions: HIV Infections; ChickenpoxIntervention: Biological: Varicella Virus Vaccine (Live)Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2001 Category: Research Source Type: clinical trials

Shingles Prevention Study
Conditions: Herpes Zoster; Postherpetic NeuralgiaInterventions: Biological: Varicella-zoster vaccine; Biological: PlaceboSponsors: Department of Veterans Affairs; Department of Veterans Affairs; Merck; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2000 Category: Research Source Type: clinical trials

Shingles Prevention Study
Conditions: Herpes Zoster; Postherpetic NeuralgiaInterventions: Biological: Varicella-zoster vaccine; Biological: PlaceboSponsors: Department of Veterans Affairs; Department of Veterans Affairs; Merck; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2000 Category: Research Source Type: clinical trials